This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: China Medical University, China Medical University Hospital, The University of North Carolina at Chapel Hill. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 110 
1 out of 21 
1 out of 1,329 
Years Active: 2016-2020
Title: Min-Tsang Hsieh: Innovator in Anticancer Research
Introduction
Min-Tsang Hsieh is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of anticancer research, holding a total of three patents. His work focuses on developing novel compounds that show promise in treating various types of cancer.
Latest Patents
One of his latest patents involves derivatives of curcuminoids and their use as anticancer agents. This series of novel bis(hydroxymethyl) alkanoate derivatives of curcuminoids has demonstrated anticancer activity, particularly against breast cancer, colon cancer, and prostate cancer. Another notable patent relates to novel 20-sulfonylamidine derivatives of camptothecin, which includes methods of synthesizing these compounds and their application as antitumor agents for treating nasopharyngeal, lung, breast, or prostate cancer.
Career Highlights
Min-Tsang Hsieh has worked at China Medical University and China Medical University Hospital, where he has contributed to various research initiatives. His innovative approaches in the laboratory have led to advancements in cancer treatment methodologies.
Collaborations
Throughout his career, Hsieh has collaborated with notable colleagues, including Sheng-Chu Kuo and Ling-Chu Chang. These partnerships have fostered a collaborative environment that enhances research outcomes.
Conclusion
Min-Tsang Hsieh's work in developing anticancer agents showcases his dedication to improving cancer treatment options. His innovative patents and collaborations highlight his significant role in the field of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile